SOLV vs MRK

	SOLV Solventum Corp	MRK Merck & Co., Inc.
Price	$85.41	$145.27
Sector	Health Care	Health Care
X-Ray Score	48	33
Valuation	67	22
Growth	27	33
Profitability	47	44
Financial health	48	21
Dividends	–	56
Fair value	$114	$116
Verdict	Undervalued +33%	Overvalued -20%
Revenue (TTM)	$8.3B	$66.6B
Operating margin	25.0%	11.6%
Return on capital	18.5%	6.1%
Revenue growth (3y)	0.8%	3.1%
Free-cash-flow yield	-0.8%	4.5%
Net debt / EBITDA	1.8×	6.1×
Dividend yield	None	2.3%

Scores and fair values are model estimates from SEC filings, ranked within each company's own sector, so scores of companies in different sectors are not directly comparable. Educational only, not financial advice.